Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD

BACKGROUND: Patients with inflammatory bowel disease (IBD) have intestinal inflammation and are treated with immune-modulating medications. In the face of the coronavirus disease-19 pandemic, we do not know whether patients with IBD will be more susceptible to infection or disease. We hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgueño, Juan F, Reich, Adrian, Hazime, Hajar, Quintero, Maria A, Fernandez, Irina, Fritsch, Julia, Santander, Ana M, Brito, Nivis, Damas, Oriana M, Deshpande, Amar, Kerman, David H, Zhang, Lanyu, Gao, Zhen, Ban, Yuguang, Wang, Lily, Pignac-Kobinger, Judith, Abreu, Maria T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Leading Off
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188157/
https://www.ncbi.nlm.nih.gov/pubmed/32333601
http://dx.doi.org/10.1093/ibd/izaa085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188157/
https://www.ncbi.nlm.nih.gov/pubmed/32333601
http://dx.doi.org/10.1093/ibd/izaa085

Ejemplares similares